Hepatitis E

Hepatitis C drug may prevent hepatitis E virus replication

by

A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating. Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of bemnifosbuvir as … Read more

A case of thrombotic thrombocytopenic purpura induced by acute hepatitis E and successfully controlled by lymphoplasmapheresis plus rituximab | Virology Journal

by

Hepatitis E virus (HEV) infection is a common cause of viral hepatitis and represents a significant global public health issue. It is often transmitted via contaminated drinking water or food, occasionally via vertical routes, blood transfusion, and sexual contact [1]. Emerging evidence suggests that HEV infection also has different extrahepatic manifestations, including kidney involvement and … Read more